Skip to main content
FinSpry Logo
FinSpry
HUMA logo
HUMA
(NASDAQ)
Humacyte, Inc.
$0.83-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Humacyte (HUMA) Stock Price & Financial Analysis

Humacyte Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.82 - $0.90
52-Week High$2.93
52-Week Low$0.55
Open$0.90
Volume4.13M
Average Volume (3M)5.87M
Market Cap142.09M
Shares Outstanding158.16M
Price to Sales (P/S)72.18
Price to Book (P/B)47.32
EV/EBITDA-1.54
Revenue (TTM)2.04M
Net Income (TTM)-40.83M
Free Cash Flow (TTM)-105.93M
EPS (TTM)$-0.27
Profit Margin-2003.58%
Operating Margin-5306.04%
Return on Equity (ROE)-1313.38%
Debt to Equity12.18
50-Day MA$0.86
200-Day MA$1.29
52-Week Change-24.24%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Humacyte

What is the current stock price for HUMA?

As of the latest trading session, HUMA stock trades at $0.83. The 52-week range is $0.55–$2.93, with a day range of $0.82–$0.90.

What is the P/E ratio for HUMA?

The P/E ratio (Price-to-Earnings) for HUMA is shown in the Key Statistics section. This valuation metric helps compare Humacyte, Inc. to industry peers.

Does HUMA pay dividends?

Humacyte does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for HUMA?

Based on 6 analysts, the consensus for HUMA is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of HUMA?

Humacyte's market capitalization is $130.5M, classifying it as a micro-cap company. Humacyte operates in the Healthcare sector within the Biotechnology industry.